Skip to main content
Watch Insiders

Corporate insider profile

Benjamin Hohl Insider Trades

Latest reported as CHIEF FINANCIAL OFFICER of Enliven Therapeutics, Inc. (ELVN).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,467,458.01
Latest transaction
Oct 19, 2026

Affiliated corporations

Reported company relationships

ELVNLatest reported

Enliven Therapeutics, Inc.

CHIEF FINANCIAL OFFICER

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 19, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICERSale6,018$38.48$231,546
Sep 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICERSale6,018$50.35$303,003
Aug 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICERSale6,018$58.58$352,551
Jul 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICERSale6,018$52.64$316,780
Jun 17, 2026Enliven Therapeutics, Inc. (ELVN)CHIEF FINANCIAL OFFICERSale6,018$43.80$263,578